UK markets open in 7 hours 19 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6500-0.1500 (-5.36%)
At close: 04:00PM EDT
2.6900 +0.04 (+1.51%)
After hours: 06:35PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.8000
Open2.8200
Bid2.6400 x 1000
Ask2.6900 x 500
Day's range2.6400 - 2.8500
52-week range0.5000 - 3.2200
Volume2,161,272
Avg. volume2,362,019
Market cap398.372M
Beta (5Y monthly)1.71
PE ratio (TTM)N/A
EPS (TTM)-0.8000
Earnings date07 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.75
  • PR Newswire

    Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

    Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, May 7, 2024, at 8:30 a.m. ET to report first quarter 2024 financial results and discuss recent business highlights.

  • PR Newswire

    Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

    Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it will host an Investor Day on Wednesday, May 15, 2024 in New York City, beginning at 9:30 am ET. The event will include presentations from members of the Company's leadership team highlighting the renewed focus across the Acute Care and Oncology franchises and panel discussions featuring patient and physician experience with Heron's commercial products. The presentations will also include up

  • PR Newswire

    Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

    Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate in a fireside chat on Wednesday, April 10, 2024, at 11:00 AM ET at the 23rd Annual Needham Virtual Healthcare Conference. The conference is being held in a virtual format, April 8-11, 2024.